Picture Berlin Partner Top News from HealthCapital Berlin-Brandenburg 650x100px

Document › Details

Arix Bioscience plc. (3/16/18). "Press Release: Results of Capital Raising [Not for United States, Australia, Canada, Japan, New Zealand, The Republic of Ireland or the Republic of South Africa or other Jursidcitions Where Unlawful]".

	Organisation	Arix Bioscience plc (LSE: ARIX)
	Today	Arix Bioscience (Group)
	Group	Arix Bioscience (Group)
	Organisation 2	London Stock Exchange plc (LSE)
	Product	venture capital
	Product 2	investment banking
	Index term	Arix Bioscience–SEVERAL: investment, 201802–201803 capital increase £87m with 38.6m new ordinary shares to new + existing investors
	Person	Anderson, Joe (Sofinnova Partners 2022 Partner before Arix Bioscience + Abingworth)
	Person 2	Milligan, Ivar (Consilium 201705)

Original document
accessed by [iito] on 2018-03-28

Record changed: 2023-06-05

Picture Berlin Partner Special Topic HealthCapital Berlin-Brandenburg 650x200px

More documents for Arix Bioscience (Group)

[1] Evommune, Inc.. (4/26/23). "Press Release: Evommune Closes $50 Million Series B Financing to Advance Broad Pipeline of Therapies to Treat Chronic Inflammatory Diseases". Palo Alto, CA....
[2] UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels....
[3] Sorriso Pharmaceuticals, Inc.. (12/22/21). "Press Release: Sorriso Pharmaceuticals Launches with $31 Million to Develop Novel Class of Orally Delivered Cytokine Antibodies to Treat Inflammatory Conditions". Salt Lake City, UT....
[4] Arix Bioscience plc. (12/22/21). "Press Release: Arix Bioscience Co-leads $31 Million Series A Financing for New Portfolio Company Sorriso Pharmaceuticals". London....
[5] Rentschler Biopharma SE. (9/20/21). "Press Release: Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer, Strengthening Scientific Focus". Laupheim & Milford, MA....
[6] Pyxis Oncology, Inc.. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA....
[7] Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London....
[8] Arix Bioscience plc. (11/5/20). "Press Release: VelosBio to Be Acquired by Merck for $2.75 Billion". London....
[9] GenSight Biologics S.A.. (10/22/20). "Press Release: GenSight Biologics Successfully Raises €25 Million in an Oversubscribed Private Placement With US and European Institutional Investors". Paris....
[10] VelosBio Inc.. (7/8/20). "Press Release: VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]